Does inflammation predispose to recurrent vascular events after recent transient ischaemic attack and minor stroke? The North West of England transient ischaemic attack and minor stroke (NORTHSTAR) study

International Journal of Stroke

Volumn 6, Issue 3, 2011, Pages 187-194

  Selvarajah, Johann R ^a   Smith, Craig J ^b   Hulme, Sharon ^c   Georgiou, Rachel ^b   Sherrington, Charles ^b   Staniland, John ^b   Illingworth, Karen J ^b   Jury, Francine ^c   Payton, Antony ^c   Ollier, William E ^c   Vail, Andy ^c   Rothwell, Nancy J ^c   Hopkins, Stephen J ^b   Tyrrell, Philippa J ^b,c  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Inflammation; Stroke; Transient ischaemic attack; Vascular events

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; ERYTHROCYTE SEDIMENTATION RATE; EVALUATION AND FOLLOW UP; FIBRINOGEN BLOOD LEVEL; GENE FREQUENCY; GENETIC MARKER; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CONFIDENCE INTERVALS; ENGLAND; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; IMMUNOASSAY; INFLAMMATION; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; SAMPLE SIZE; SOCIOECONOMIC FACTORS; STROKE; TREATMENT OUTCOME;

EID: 79955760979     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00561.x     Document Type: Article

References (36)

1. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6:508-19.
2. Rost NS, Wolf PA, Kase CS et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke 2001; 32:2575-9.
3. Blake GJ, Ridker PM. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. Arterioscler Thromb Vasc Biol 2002; 22:1512-3.
4. Elkind MS, Sciacca RR, Boden-Albala B, Paik MC, Sacco RL. Relative elevation in baseline leukocyte count predicts first cerebral infarction. Neurology 2005; 64:2121-5.
5. Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 2006; 48:2235-42.
6. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 2002; 22:1399-419.
7. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol 2007; 20:334-42.
8. Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008; 7:341-53.
9. Emsley HC, Smith CJ, Gavin CM et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003; 139:93-101.
10. Um JY, Moon KS, Lee KM, Kim HM. Interleukin-1 gene cluster polymorphisms in cerebral infarction. Cytokine 2003; 23:41-6.
11. Flex A, Gaetani E, Papaleo P et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004; 35:2270-5.
12. Emsley HC, Smith CJ, Georgiou RF et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 2005; 76:1366-72.
13. Rothwell PM, Johnston SC. Transient ischemic attacks: stratifying risk. Stroke 2006; 37:320-2.
14. Selvarajah JR, Smith CJ, Hulme S et al. Prognosis in patients with transient ischaemic attack (TIA) and minor stroke attending TIA services in the North West of England: the NORTHSTAR Study. J Neurol Neurosurg Psychiatry 2008; 79:38-43.
15. Dennis MS, Bamford JM, Sandercock PA, Warlow CP. A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project. Stroke 1989; 20:1494-9.
16. Hankey GJ, Warlow CP. Transient Ischaemic Attacks of the Brain and Eye. London: W. B. Saunders, 1994.
17. Holt I, Cooper RG, Hopkins SJ. Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur J Clin Invest 1991; 21:479-84.
18. Clauss A. Gerinnung s physiologische Schell methode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17:237-46.
19. Purroy F, Montaner J, Molina CA et al. C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 2007; 115:60-6.
20. Cucchiara BL, Messe SR, Sansing L et al. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke 2009; 40:2332-6.
21. Smith CJ, Emsley HC, Vail A et al. Variability of the systemic acute phase response after ischemic stroke. J Neurol Sci 2006; 251:77-81.
22. Albert MA, Danielson E, Rifai N, Ridker PM, PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001; 286:64-70.
23. Rothwell PM, Howard SC, Power DA et al. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke 2004; 35:2300-5.
24. Tanne D, Benderly M, Goldbourt U et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 2006; 37:1720-4.
25. Chamorro A, Vila N, Ascaso C et al. Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. Stroke 1995; 26:573-6.
26. Vila N, Filella X, Deulofeu R et al. Cytokine-induced inflammation and long-term stroke functional outcome. J Neurol Sci 1999; 162:185-8.
27. Andresdottir MB, Sigfusson N, Sigvaldason H, Gudnason V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am J Epidemiol 2003; 158:844-51.
28. Saadeh C. The erythrocyte sedimentation rate: old and new clinical applications. South Med J 1998; 91:220-5.
29. Vandenbroeck K. Cytokine Gene Polymorphisms in Multifactorial Conditions. Florida: Taylor & Francis Group, 2006.
30. Tso AR, Merino JG, Warach S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 2007; 38:3070-5.
31. Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariëns RA. Functional analysis of the fibrinogen alpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation 2003; 107:2326-30.
32. Silander K, Alanne M, Kristiansson K et al. Gender differences in genetic risk profiles for cardiovascular disease. PLoS One 2008; 3:e3615.
33. Reiner AP, Carlson CS, Thyagarajan B et al. Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol 2008; 28:1549-55.
34. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E. P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the atherosclerosis risk in communities study. Atherosclerosis 2006; 186:74-9.
35. Kawanami D, Maemura K, Takeda N et al. C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells. Atherosclerosis 2006; 185:39-46.
36. Miyoshi T, Yuan Z, Shi W. Association of a Vcam1 mutation with atherosclerosis susceptibility in diet-induced models of atherosclerosis. Atherosclerosis 2008; 196:234-9.